{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:08:35Z","timestamp":1768874915415,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,7,6]],"date-time":"2008-07-06T00:00:00Z","timestamp":1215302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00347-008-1782-3","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T13:12:42Z","timestamp":1215177162000},"page":"435-442","source":"Crossref","is-referenced-by-count":3,"title":["Intraokulare Bevacizumab-Injektionen bei seltenen Indikationen \u2013 zwei Kasuistiken","Intraocular injections of bevacizumab in rare indications \u2013 two cases"],"prefix":"10.1007","volume":"106","author":[{"given":"T.","family":"Wecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Behrens-Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,6]]},"reference":[{"key":"1782_CR1","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00417-007-0637-y","volume":"245","author":"Alfredo","year":"2007","unstructured":"Alfredo A et al. (2007) Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Graefes Arch Clin Exp Ophthalmol 245: 1873\u20131875","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1782_CR2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","volume":"113","author":"Avery","year":"2006","unstructured":"Avery RL, Pearlman J, Pieramici DJ et al. (2006) Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113: 1695\u20131705","journal-title":"Ophthalmology"},{"key":"1782_CR3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD et al. (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113: 363\u2013372","journal-title":"Ophthalmology"},{"key":"1782_CR4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00347-006-1351-6","volume":"103","author":"Bartz-Schmidt","year":"2006","unstructured":"Bartz-Schmidt KU, Holz FG (2006) Bevacizumab-Therapie im \u201eoff label use\u201cbei der neovaskul\u00e4ren altersabh\u00e4ngigen Makuladegeneration. Ophthalmologe 103: 461\u2013462","journal-title":"Ophthalmologe"},{"key":"1782_CR5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2005.02.011","volume":"112","author":"Browning","year":"2005","unstructured":"Browning AC, Chung AK, Ghanchi F et al. (2005) Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series. Ophthalmology 112: 1227\u20131231","journal-title":"Ophthalmology"},{"key":"1782_CR6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.2004.030171","volume":"42","author":"Chassaing","year":"2005","unstructured":"Chassaing N, Martin L, Calvas P et al. (2005) Pseudoxanthoma elasticum: a clinical, pa thophysiological and genetic upda te including 11 no vel ABCC6 mutations. J Med Genet 42: 881\u2013892","journal-title":"J Med Genet"},{"key":"1782_CR7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9343(61)90078-X","volume":"30","author":"Connor","year":"1961","unstructured":"Connor PJ jr, Juergens JL, Perry HO et al. (1961) Pseudoxanthoma elasticum and angioid streaks. A review of 106 cases. Am J Med 30: 537\u2013543","journal-title":"Am J Med"},{"key":"1782_CR8","first-page":"158","volume":"31","author":"Dreyer","year":"1978","unstructured":"Dreyer R, Green WR (1978) The pathology of angioid streaks: a study of twenty-one cases. Trans Pa Acad Ophthalmol Otolaryngol 31: 158\u2013167","journal-title":"Trans Pa Acad Ophthalmol Otolaryngol"},{"key":"1782_CR9","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","volume":"245","author":"Eun","year":"2007","unstructured":"Eun Jee Chung et al. (2007) Combination of laser photocoagulation and intravitreal bevacizumab (Avastin\u00ae) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 245:1727\u20131730","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1782_CR10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-2006-926875","volume":"223","author":"Geitzenauer","year":"2006","unstructured":"Geitzenauer W, Michels S, Prager F et al. (2006) Fr\u00fche Effekte nach systemischer und intravitrealer Bevacizumab (Avastin\u00ae)-Therapie bei neovaskul\u00e4rer altersbedingter Makuladegeneration. Klin Monatsbl Augenheilkd 223: 822\u2013827","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1782_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00006982-199707000-00002","volume":"17","author":"Giovannini","year":"1997","unstructured":"Giovannini A, Scassellati-Sforzolini BD, Altobrando E (1997) Chorioidal findings in the course of idiopathic serous pigment epithelium detachment detected by indocyanine green videoangiography. Retina 17: 286\u2013293","journal-title":"Retina"},{"key":"1782_CR12","first-page":"472","volume":"Ophthalmol","author":"Groenblad","year":"1958","unstructured":"Groenblad E (1958) Color photographs of angioid streaks in the late stages. Acta Ophthalmol (Copenh) 36: 472\u2013474","journal-title":"Acta"},{"key":"1782_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1525-1470.1993.tb00005.x","volume":"10","author":"Hacker","year":"1993","unstructured":"Hacker SM, Ramos-Caro FA, Beers BB, Flowers FP (1993) Juvenile pseudoxanthoma elasticum: recognition and management. Pediatr Dermatol 10: 19\u201325","journal-title":"Pediatr Dermatol"},{"key":"1782_CR14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ophtha.2005.10.052","volume":"113","author":"Heier","year":"2006","unstructured":"Heier JS, Antoszyk AN, Pavan PR et al. (2006) Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I\/II multicenter, controlled, multidose study. Ophthalmology 113(4): 642.e1\u20134. Epub 2006 Feb 14","journal-title":"Ophthalmology"},{"key":"1782_CR15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0039-6257(03)00053-5","volume":"48","author":"Hu","year":"2003","unstructured":"Hu X, Plomp AS, Van Soest S et al. (2003) Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol 48: 424\u2013438","journal-title":"Surv Ophthalmol"},{"key":"1782_CR16","unstructured":"Hussain D, Gass JDM (1998) Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 3 131\u2013137"},{"key":"1782_CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00006982-200603000-00005","volume":"26","author":"Iturralde","year":"2006","unstructured":"Iturralde D, Spaide RF, Meyerle CB et al. (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion. A short-term study. Retina 26: 279\u2013284","journal-title":"Retina"},{"key":"1782_CR18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00347-006-1355-2","volume":"103","author":"Jaissle","year":"2006","unstructured":"Jaissle GB, Ziemssen F, Petermeier K et al. (2006) Bevacizumab zur Therapie des sekund\u00e4ren Makula\u00f6dems nach ven\u00f6sen Gef\u00e4\u00dfverschl\u00fcssen. Ophthalmologe 103: 471\u2013475","journal-title":"Ophthalmologe"},{"key":"1782_CR19","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00417-006-0468-2","volume":"245","author":"Jorge","year":"2007","unstructured":"Jorge R et al. (2007) Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 245: 1045\u20131048","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1782_CR20","unstructured":"Kaiser P, ANCHOR Study Group (2006) ANCHOR DATA (year one results). Macula 2006, paper presentation, New York NY USA"},{"key":"1782_CR21","first-page":"289","volume":"21","author":"Knapp","year":"1892","unstructured":"Knapp H (1892) On the formation of dark angioid streaks as an unusual metamorphosis of retinal hemorrage. Arch Ophthalmol 21: 289\u2013292","journal-title":"Arch Ophthalmol"},{"key":"1782_CR22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0002-9394(73)90076-7","volume":"76","author":"Krill","year":"1973","unstructured":"Krill AE, Klien BA, Archer DB (1973) Precursors of angioid streaks. Am J Ophthalmol 76: 875\u2013879","journal-title":"Am J Ophthalmol"},{"key":"1782_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3129\/can j ophthalmol.i07-026","volume":"42","author":"Kumar","year":"2007","unstructured":"Kumar A, Sinha S (2007) Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab. Can J Ophthalmol 42(2): 335","journal-title":"Can J Ophthalmol"},{"key":"1782_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00347-006-1352-5","volume":"103","author":"Ladewig","year":"2006","unstructured":"Ladewig MS, Ziemssen F, Jaissle G et al. (2006) Intravitreales Bevacizumab bei der neovaskul\u00e4ren altersabh\u00e4ngigen Makuladegeneration. Ophthalmologe 103: 463\u201370","journal-title":"Ophthalmologe"},{"key":"1782_CR25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM199310213291705","volume":"329","author":"Lebwohl","year":"1993","unstructured":"Lebwohl M, Halperin J, Phelps RG (1993) Brief report: occult pseudoxanthoma elasticum in patients with premature cardiovascular disease. N Engl J Med 329: 1237\u20131239","journal-title":"N Engl J Med"},{"key":"1782_CR26","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9394(14)71398-4","volume":"116","author":"Lim","year":"1993","unstructured":"Lim JI, Bressler NM, Marsh MJ, Bressler SB (1993) Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 116: 414\u2013423","journal-title":"Am J Ophthalmol"},{"key":"1782_CR27","first-page":"148","volume":"12","author":"Lipowsky","year":"1971","unstructured":"Lipowsky ZJ, Kiriakos RZ (1971) Psychosomatic aspects of central serous chorioretinopathy. Psychosom Med 12: 148\u2013161","journal-title":"Psychosom Med"},{"key":"1782_CR28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00347-006-1456-y","volume":"104","author":"Lommatzsch","year":"2007","unstructured":"Lommatzsch et al. (2007) Intraokulare Injektion von Bevacizumab Eine m\u00f6gliche Therapie der sekund\u00e4ren CNV bei \u201eangioid streaks\u201c. Ophthalmologe 104: 325\u2013328","journal-title":"Ophthalmologe"},{"key":"1782_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00347-006-1353-4","volume":"103","author":"Ladewig","year":"2006","unstructured":"Ladewig MS (2006) Pseudoxanthoma elasticum Genetische Grundlagen, Manifestationen und therapeutische Ans\u00e4tze. Ophthalmologe 103: 537\u2013553","journal-title":"Ophthalmologe"},{"key":"1782_CR30","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0161-6420(84)34113-6","volume":"91","author":"Olk","year":"1984","unstructured":"Olk JR, Burgess DB, McCormick PA (1984) Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome (POHS): visual prognosis. Ophthalmology 91: 1592\u20131602","journal-title":"Ophthalmology"},{"key":"1782_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006982-200202000-00005","volume":"22","author":"Otsuka","year":"2002","unstructured":"Otsuka S, Ohba N, Nakao K (2002) A Long-Term Follow-Up Study of Severe Variant Of Central Serous Chorioretinopathy. Retina 22: 25\u201332","journal-title":"Retina"},{"key":"1782_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000250179","volume":"163","author":"Pasquali-Ronchetti","year":"1981","unstructured":"Pasquali-Ronchetti I, Volpin D, Baccarani-Contri M et al. (1981) Pseudoxanthoma elasticum. Biochemical and ultrastructural studies. Dermatologica 163: 307\u2013325","journal-title":"Dermatologica"},{"key":"1782_CR33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00006982-199701000-00003","volume":"17","author":"Pece","year":"1997","unstructured":"Pece A, Avanza P, Galli L, Brancato R (1997) Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina 17: 12\u201316","journal-title":"Retina"},{"key":"1782_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000310498","volume":"208","author":"Pierro","year":"1994","unstructured":"Pierro L, Brancato R, Minicucci M, Pece A (1994) Echographic diagnosis of Drusen of the optic nerve head in patients with angioid streaks. Ophthalmologica 208: 239\u2013242","journal-title":"Ophthalmologica"},{"key":"1782_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2133.1975.tb03117.x","volume":"92","author":"Pope","year":"1975","unstructured":"Pope FM (1975) Historical evidence for the genetic heterogeneity of pseudoxanthoma elasticum. Br J Dermatol 92: 493\u2013509","journal-title":"Br J Dermatol"},{"key":"1782_CR36","doi-asserted-by":"crossref","unstructured":"Pr\u00fcnte C, Flammer J (1996) Chorioidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121 26\u201334","DOI":"10.1016\/S0002-9394(14)70531-8"},{"key":"1782_CR37","first-page":"361","volume":"19","author":"Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Rich RM, Lalwani GA (2006) Ranibizumab: Phase III clinical trial results. Ophthalmol Clin North Am 19(3): 361\u201372","journal-title":"Ophthalmol Clin North Am"},{"key":"1782_CR38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9394(00)00809-6","volume":"131","author":"Roth","year":"2001","unstructured":"Roth DB, Estafanous M, Lewis H (2001) Macular translocation for subfoveal choroidal neovascularization in angioid streaks. Am J Ophthalmol 131: 390\u2013392","journal-title":"Am J Ophthalmol"},{"key":"1782_CR39","first-page":"1290","volume":"59","author":"Schneider","year":"1984","unstructured":"Schneider T, Apel HP, Kuhlwein A et al. (1984) Groenblad-Strandberg Syndrom. Z Hautkrankh 59: 1290\u20131292, 1297\u20131300","journal-title":"Z Hautkrankh"},{"key":"1782_CR40","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archopht.116.10.1333","volume":"116","author":"Secretan","year":"1998","unstructured":"Secretan M, Zografos L, Guggisberg D, Piguet B (1998) Chorioretinal vascular abnormalities associated with angioid streaks and pseudoxanthoma elasticum. Arch Ophthalmol 116: 1333\u20131336","journal-title":"Arch Ophthalmol"},{"key":"1782_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bjo.59.5.257","volume":"59","author":"Shields","year":"1975","unstructured":"Shields JA, Federman JL, Tomer TL, Annesley WH jr (1975) Angioid streaks. I. Ophthalmoscopic variations and diagnostic problems. Br J Ophthalmol 59: 257\u2013266","journal-title":"Br J Ophthalmol"},{"key":"1782_CR42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/PL00007893","volume":"238","author":"Sibayan","year":"2000","unstructured":"Sibayan SAB, Kobuch K, Spiegel D et al. (2000) Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 238: 515\u2013519","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1782_CR43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","volume":"26","author":"Spaide","year":"2006","unstructured":"Spaide RF, Laud K, Fine HF et al. (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26: 383\u2013390","journal-title":"Retina"},{"key":"1782_CR44","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","volume":"110","author":"Spaide","year":"2003","unstructured":"Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 1517\u20131525","journal-title":"Ophthalmology"},{"key":"1782_CR45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0039-6257(84)90226-1","volume":"28","author":"Stark","year":"1984","unstructured":"Stark WJ jr, Maumenee AE, Fagadau W et al. (1984) Cystoid macular edema in pseudophakia. Surv Ophthalmol 28: 442\u2013451","journal-title":"Surv Ophthalmol"},{"key":"1782_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00006982-200001000-00020","volume":"20","author":"Thoelen","year":"2000","unstructured":"Thoelen AM, Bernasconi PP, Schmid C, Messmer E (2000) Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina 20: 98\u201399","journal-title":"Retina"},{"key":"1782_CR47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9394(99)00075-6","volume":"128","author":"Tittl","year":"1999","unstructured":"Tittl MK, Spaide RF, Wong D (1999) Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 128: 63\u201368","journal-title":"Am J Ophthalmol"},{"key":"1782_CR48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00347-006-1356-1","volume":"103","author":"V\u00f6lcker","year":"2006","unstructured":"V\u00f6lcker S, Peters W, Inhoffen F, Ziemssen (2006) Fr\u00fcher antiexsudativer Effekt \u2013 OCT-Monitoring nach intravitrealer Bevacizumab-Applikation. Ophthalmologe 103: 476\u2013483","journal-title":"Ophthalmologe"},{"key":"1782_CR49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature03987","volume":"437","author":"Weis","year":"2005","unstructured":"Weis SM, Cheresh DA (2005) Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497\u2013504","journal-title":"Nature"},{"key":"1782_CR50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.mn.7800164","volume":"9","author":"Whittles","year":"2002","unstructured":"Whittles CE, Pocock TM, Wedge SR et al. (2002) ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity. Microcirculation 9: 513\u2013522","journal-title":"Microcirculation"},{"key":"1782_CR51","doi-asserted-by":"crossref","unstructured":"Yannuzzi L.A (1987) Type A behavior and central serous chorioretinopathy. Retina 7 111\u2013130","DOI":"10.1097\/00006982-198700720-00009"},{"key":"1782_CR52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000309239","volume":"185","author":"Yoshioka","year":"1982","unstructured":"Yoshioka H, Katsume Y, Akune H (1982) Experimental central serous chorioretinopathy in monkey eyes: Fluoreszein angiographic findings. Ophthalmology 185: 168\u2013178","journal-title":"Ophthalmology"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1782-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-008-1782-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1782-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T22:46:35Z","timestamp":1631486795000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-008-1782-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,6]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["1782"],"URL":"https:\/\/doi.org\/10.1007\/s00347-008-1782-3","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,6]]}}}